News

Merck's Enflonsia vaccine for respiratory syncytial virus won approval from the Centers for Disease Control and Prevention's ...
A CDC advisory panel on Thursday voted 5-2 to recommend the use of a new preventative RSV therapy in babies, Merck’s ...
A new slate of vaccine advisers to the US Centers for Disease Control and Prevention voted Thursday to recommend that ...
By a 5-2 vote, the Advisory Committee on Immunization Practices endorsed Merck’s Enflonsia for babies born during or entering ...
The CDC’s Advisory Committee on Immunization Practices (ACIP) has blessed Merck’s new respiratory syncytial virus (RSV) shot ...
Concerns raised by University of Minnesota’s Dr. David Boulware correct record before a federal vaccine advisory committee ...
U.S. Health Secretary Robert F. Kennedy Jr.'s newly revamped vaccine advisory panel voted on Thursday for recommending use of ...
The effective removal of thimerosal from influenza vaccines would have limited impact, but it illustrates how the ...
The votes in favor of Merck’s shot are a sigh of relief after Kennedy gutted the panel and tapped replacements, some of whom ...
The meeting, scheduled for June 25-26, will review existing data and vote on RSV and influenza vaccines, along with ...
An advisory panel of the U.S. Centers for Disease Control and Prevention on Thursday recommended the use of Merck's ...